Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Breast Cancer Research and Treatment
|
August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Oncology
|
September 7, 2016
Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors
Emiliano Calvo, Fadi Braiteh, Daniel Von Hoff, et al.
Hepatology (Baltimore, Md.)
|
September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study
Mitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Exon Utilization Improves Risk Stratification for Advanced Heart Failure in Titin Cardiomyopathy
Peter Deckerman, Jihyeon Lee, Aleksandra Binek, et al.
BMC Cancer
|
February 17, 2017
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
Berta Laquente, Jose Lopez-Martin, Donald Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology
Nasser Hanna, Marcus Neubauer, Constantin Yiannoutsos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer
Minal Barve, James Bender, Neil Senzer, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
Milind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
European Urology
|
May 22, 2024
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146
Chung-Han Lee, Amishi Yogesh Shah, Arpit Rao, et al.
Clinical Breast Cancer
|
June 5, 2019
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study
Denise A Yardley, Lowell Hart, Anne Favret, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Breast Cancer Research and Treatment
|
August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Oncology
|
September 7, 2016
Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors
Emiliano Calvo, Fadi Braiteh, Daniel Von Hoff, et al.
Hepatology (Baltimore, Md.)
|
September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study
Mitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Exon Utilization Improves Risk Stratification for Advanced Heart Failure in Titin Cardiomyopathy
Peter Deckerman, Jihyeon Lee, Aleksandra Binek, et al.
BMC Cancer
|
February 17, 2017
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
Berta Laquente, Jose Lopez-Martin, Donald Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology
Nasser Hanna, Marcus Neubauer, Constantin Yiannoutsos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer
Minal Barve, James Bender, Neil Senzer, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
Milind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
European Urology
|
May 22, 2024
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146
Chung-Han Lee, Amishi Yogesh Shah, Arpit Rao, et al.
Clinical Breast Cancer
|
June 5, 2019
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study
Denise A Yardley, Lowell Hart, Anne Favret, et al.
Page
of 4